{"brief_title": "A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients", "brief_summary": "To characterize the safety and efficacy of fixed doses of MDL 28,574A administered alone and in combination with zidovudine ( AZT ) in patients with asymptomatic or mildly symptomatic HIV infection. To examine the demographic effects on population pharmacokinetics and pharmacodynamics of MDL 28,574A alone and in combination with AZT.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Celgosivir hydrochloride", "criteria": "Inclusion Criteria Concurrent Medication: Allowed: - Prior antiretroviral agents for up to 6 months per agent. Patients must have: - HIV infection. - Asymptomatic or mildly symptomatic. - CD4 count 301 - 500 cells/mm3. Exclusion Criteria Co-existing Condition: Patients with the following condition are excluded: Unable or unwilling to comply with study procedures. Concurrent Medication: Excluded: - Chemoprophylactic therapy for mycobacterial infection. - Any nonstudy prescription medications without approval of investigator. Patients with the following prior conditions are excluded: - History of grade 3 or 4 toxicity to <= 600 mg/day AZT. - History of intolerance to lactose. - Chronic diarrhea within 6 months prior to study entry. - Unexplained intermittent or chronic fever, defined as temperature >= 38.5 C for any 7 days within the 30 days prior to study entry. Prior Medication: Excluded: - Antiretroviral therapy within 2 weeks prior to study entry. - Prior HIV vaccines. - Biological response modifiers within 30 days prior to study entry. - Prior foscarnet. - Any investigational drug with a washout < 5 half-lives prior to study entry. - Any medications known to alter renal, hepatic, or hematologic / immunologic function (such as barbiturates, phenothiazines, cimetidine, immunomodulators, etc.) within 14 days prior to study entry. Recent history of alcohol and/or drug abuse.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00002151.xml"}